Literature DB >> 31621782

Aspects of Non-Pharmacological Treatment in Peripheral Arterial Disease.

Maria Janieire de N Nunes Alves1, Francis Ribeiro de Souza1.   

Abstract

Entities:  

Year:  2019        PMID: 31621782      PMCID: PMC6882388          DOI: 10.5935/abc.20190208

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


× No keyword cloud information.
Peripheral arterial disease (PAD) is one of the main atherosclerotic diseases in the elderly population[1] which limits the performance of physical activity. Patients with PAD who have intermittent claudication may have gait impairment, which compromises daily living activities.[2] In addition, these patients have other comorbidities that may increase cardiovascular risk.[1,3] Regular exercise is a non-drug treatment recommended for the prevention and treatment of cardiovascular disease. On the other hand, maintaining adherence to a physical training program becomes a major challenge. The present study[4] exposes the physical activity pattern of patients with PAD and demonstrates the high rate of a sedentary lifestyle with aging. In fact, the disease itself leads to physical limitation, which in turn is also a worsening factor of the disease, since the recommendation of vigorous physical activity has therapeutic effects that contribute, in addition to the chronic use of arterial vasodilator drugs. In addition, chronic arterial vasodilation due to the use of medications may lead to reduced long-term peripheral flow, as arterial vasodilation promoted by medication further reduces perfusion pressure in the lower limb peripheral muscles and intensifies the low level of physical activity in patients with PAD, according to current physical activity recommendations. The assessment of the degree of physical activity was performed by a device over a period of 7 days, and the data are relevant in classifying the degree of physical limitation with aging, as well as, demonstrating the significance of sedentary lifestyle, may corroborate to further aggravate the disease and cardiovascular risk. On the other hand, the device does not evaluate or quantify localized muscular resistance training (strength), which may underestimate the results pointed out by the study. Clearly, the importance of developing strategies for these patients to engage in regular exercise. The main reason for these patients with PAD not progressing with physical training is pain related to increased muscle energy demand, called intermittent claudication, especially in the calf region during walking.[5] Moderate to vigorous exercise can precipitate the symptoms of intermittent claudication and this becomes a barrier for these patients to engage in physical activity. Thus, low intensity and progressive aerobic exercise can be used as a strategy to delay these symptoms. In addition, patients with intermittent claudication have muscle atrophy, and reduced muscle strength and endurance in the lower limbs increase the fragility of these patients, especially with aging.[6] In this aspect, strength exercises and peripheral muscular endurance (bodybuilding) should be used. Although the literature recommends exercises with aerobic characteristics, such as walking, as the main exercise modality for these patients with PAD, muscle overload exercises have also been recommended as part of a physical exercise program in this population.[7,8] Regular exercise should be used as a non-pharmacological tool for the treatment and prevention of cardiovascular disease in patients with PAD and intermittent claudication, so it is important to develop a specific exercise program, especially to delay the onset of symptoms. intermittent claudication, because, besides preventing the onset of pain and the interruption of exercise, it can be a motivational factor that will imply the adherence of these patients to physical activity.
  8 in total

Review 1.  Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).

Authors:  J A Dormandy; R B Rutherford
Journal:  J Vasc Surg       Date:  2000-01       Impact factor: 4.268

2.  Effects of supervised treadmill-walking training on strength and endurance of the calf muscles of individuals with peripheral arterial disease.

Authors:  Jianxiong Wang; Shi Zhou; Roger Bronks; John Graham; Stephen Myers
Journal:  Clin J Sport Med       Date:  2006-09       Impact factor: 3.638

Review 3.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.

Authors:  Alan T Hirsch; Ziv J Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth A Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Sharon A Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2006-03-21       Impact factor: 29.690

4.  Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response.

Authors:  W R Hiatt; E E Wolfel; R H Meier; J G Regensteiner
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

5.  Exercise training improves functional status in patients with peripheral arterial disease.

Authors:  J G Regensteiner; J F Steiner; W R Hiatt
Journal:  J Vasc Surg       Date:  1996-01       Impact factor: 4.268

Review 6.  Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.

Authors:  F Gerald R Fowkes; Diana Rudan; Igor Rudan; Victor Aboyans; Julie O Denenberg; Mary M McDermott; Paul E Norman; Uchechukwe K A Sampson; Linda J Williams; George A Mensah; Michael H Criqui
Journal:  Lancet       Date:  2013-08-01       Impact factor: 79.321

7.  Chronic changes in skeletal muscle histology and function in peripheral arterial disease.

Authors:  J G Regensteiner; E E Wolfel; E P Brass; M R Carry; S P Ringel; M E Hargarten; E R Stamm; W R Hiatt
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

8.  Physical Activity Levels in Peripheral Artery Disease Patients.

Authors:  Aline Mendes Gerage; Marilia de Almeida Correia; Paulo Mesquita Longano de Oliveira; Aline Cabral Palmeira; Wagner Jorge Ribeiro Domingues; Antônio Eduardo Zeratti; Pedro Puech-Leão; Nelson Wolosker; Raphael Mendes Ritti-Dias; Gabriel Grizzo Cucato
Journal:  Arq Bras Cardiol       Date:  2019-07-29       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.